Sign inJoin waitlistJoin the waitlist

TC

Theodore Crandall

Physician · BUTLER CANCER ASSOCIATES

Credentials: ·

History

BUTLER CANCER ASSOCIATES
Present

Research

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer
Clinical Colorectal Cancer · 2012 · 13 citations
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer
Clinical Colorectal Cancer · 2011 · 4 citations
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial
The Oncologist · 2023 · 3 citations

BL
Barry Lembersky
2 papers
RR
Ramesh Ramanathan
2 papers
RP
Richard Pinkerton
2 papers
Al Benson
1 paper
Barbara Burtness
1 paper
Benedito Carneiro
1 paper
EM
Edith Mitchell
1 paper
EB
Edward Balaban
1 paper
ED
Efrat Dotan
1 paper
George Fisher
1 paper
Herbert Zeh
1 paper
KR
Kiran Rajasenan
1 paper